BIOVIC-B Biovica International AB (publ)
0.2920SEK-3.95%Mkt Cap: 8.15M $P/E: —1d ago
Biovica International AB (publ), a biotech company, develops and commercializes blood-based biomarker assays for oncologists monitor cancer progression in the European Union, the United States, and Asia. The company enga…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
Biovica International AB (STU:9II) (Q1 2027) Earnings Call Highlights: Pharma Services Surge ... Biovica International AB (STU:9II) posted 56% net sales growth on booming pharma demand, but flat US IVD revenue and ongoing cash burn keep the path to profitability uncertain. | ||